What is Hemant Surgical Industries Ltd (543916) share price return in the past 10 years?

Data is not available for this company

What is the share price of Hemant Surgical Industries Ltd (543916)?

Company share prices are keep on changing according to the market conditions. The current trading price of Hemant Surgical Industries Ltd (543916) on 04-Jun-2026 16:59:59 at 16:59 is 381.35.

What is the P/E ratio of Hemant Surgical Industries?

The latest standalone P/E ratio of Hemant Surgical Industries as of 04-Jun-2026 is 30.40.

What is the P/B ratio of Hemant Surgical Industries Ltd (543916)?

The latest standalone P/B ratio of Hemant Surgical Industries Ltd (543916) as of 04-Jun-2026 is 3.86.

What is the 52-week high and low of Hemant Surgical Industries Ltd (543916)?

The 52-week high of Hemant Surgical Industries Ltd (543916) is Rs. 446.00 and the 52-week low is Rs. 89.99.

Hemant Surgical Industries Ltd (543916) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Hemant Surgical Industries Ltd (543916)
Brand: Hemant Surgical Industries

Key Metrics

Valuation Multiples

Market Cap

₹554 Cr.

Current Price

₹381.4

52-Week Low / High

₹90 / 446

TTM EPS

₹12.5

TTM Sales

₹231 Cr.

Book Value per Share

₹98.9

P/E Ratio

30.40

Higher than its 5-year historical median

Industry PE

111.2

Price to Book (P/B)

3.86

Higher than its 5-year historical median

Price to Sales (P/S)

2.40

Higher than its 5-year historical median

EV/EBITDA

19.77

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

13.80%

Underperforms industry median

Return on Capital Employed (ROCE)

16.58%

Underperforms industry median

Return on Assets (ROA)

6.57%

Operating Profit Margin

9.7%

Net Profit Margin

7.63%

Gross Profit Margin

11.3%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

0.87%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-12.13%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-17.04%

Asset Quality

Promoter Holding

58.90%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹129 Cr.

Equity

₹14.5 Cr.

Face Value

₹10

All Time Low / High

₹88.15 / 446.00

Hemant Surgical Industries stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Weak

Check Price chart

Q.1 Is Hemant Surgical Industries Ltd a good quality company?

Hemant Surgical Industries Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Hemant Surgical Industries Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Hemant Surgical Industries Ltd vs industry peers?

Hemant Surgical Industries Ltd revenue CAGR is 13.68%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Hemant Surgical Industries Ltd?

Promoters hold 58.90% of the Hemant Surgical Industries Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Hemant Surgical Industries Ltd over the last decade?

Over the last 1 year(s), the stock has delivered a CAGR of 323.09% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	15.7%	14.8%	14.5%	15.2%	11.6%	14.3%	32.9%	45.2%	29.9%	16.6%	-
Value Creation Index ⓘ	0.1	0.1	0.0	0.1	-0.2	0.0	1.4	2.2	1.1	0.2	-
Growth Parameters ⓘ
Sales ⓘ	39.6	51.5	50.6	55.7	56.1	59.8	104	109	106	107	231
Sales YoY Gr.	-	30%	-1.8%	10.1%	0.8%	6.5%	73.3%	5.4%	-3.2%	0.9%	-
Adj EPS ⓘ	2.6	2.8	2.9	3.5	2.7	3.6	10.6	8.6	7.8	6.5	12.5
YoY Gr.	-	6.1%	5.8%	20.8%	-24.3%	33.6%	195.5%	-18.5%	-9.1%	-17.4%	-
BVPS (₹) ⓘ	20.4	20.2	21	23.7	25.1	26.7	41.1	30.4	52.6	60.3	98.9
Adj Net Profit ⓘ	0.6	0.8	0.9	1.1	0.9	1.1	3.4	6.6	8.2	6.8	18
Cash Flow from Ops. ⓘ	0	0	0	0	0	-0.3	12.1	6.3	-4.2	8.9	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	-53.4	0.8	1.1	-1.6	3.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	11.6%	13.7%	0.9%	0.9%
Adj EPS ⓘ	10.6%	19.3%	-15.1%	-17.4%
BVPSⓘ	12.8%	19.2%	13.7%	14.8%
Share Price	-	-	28.5%	313.3%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	13.3	14.9	15	15.8	11	12.9	29.5	36.3	20.9	11.5	15.8
Op. Profit Mgn % ⓘ	5.9	4.7	4.9	4.8	4.6	5.9	6.1	9.7	9.9	9.7	NAN
Net Profit Mgn % ⓘ	1.6	1.6	1.9	2	1.5	1.9	3.3	6.1	7.8	6.4	7.9
Debt to Equity ⓘ	2.3	1.9	1.3	1.5	1.8	1.7	0.7	0.3	0.1	0.5	-
Working Cap Days ⓘ	216	150	140	142	168	171	114	132	185	255	0
Cash Conv. Cycle ⓘ	53	32	14	5	18	30	20	17	35	77	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	40	51	51	56	56	60	104	109	106	107
Operating Expenses ⓘ +	37	49	48	53	54	57	97	99	95	97
Manufacturing Costs	1	1	1	1	2	1	1	2	2	2
Material Costs	33	44	42	45	44	47	82	80	78	76
Employee Cost	1	1	2	2	2	3	5	6	6	7
Other Costs ⓘ	2	2	4	5	5	6	10	11	10	12
Operating Profit ⓘ	2	2	2	3	3	3	6	11	10	9
Operating Profit Margin (%)	5.9%	4.7%	4.9%	4.8%	4.6%	5.1%	6.1%	9.7%	9.9%	8.6%
Other Income ⓘ +	0	0	0	0	0	1	2	2	4	5
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2	2	1	1	1	2	2	2	1	2
Depreciation ⓘ	0	0	0	1	1	1	1	1	1	1
Profit Before Tax ⓘ	1	1	1	1	1	2	6	10	13	11
Tax ⓘ	0	0	0	0	0	0	1	2	3	2
Profit After Tax	1	1	1	1	1	1	5	8	10	8
PAT Margin (%)	1.6%	1.6%	1.9%	2.0%	1.5%	1.9%	4.5%	7.0%	9.3%	7.6%
Adjusted EPS (₹)	2.6	2.8	2.9	3.5	2.7	3.6	14.4	9.9	9.4	7.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Hemant Surgical Inds - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	5	6	7	8	8	9	13	23	55	63
Share Capital ⓘ	2	2	2	2	2	2	2	8	10	10
Reserves ⓘ	3	4	5	6	6	7	11	16	44	53
Debt +	11	11	9	11	14	13	9	5	6	27
Long Term Debt	3	3	5	6	9	10	4	3	4	23
Short Term Debt	8	8	4	5	5	3	4	2	2	3
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	10	9	12	12	15	13	21	24	25	39
Others Liabilities ⓘ	2	1	1	2	4	8	12	12	15	19
Total Liabilities ⓘ	28	27	28	33	41	43	54	65	100	147
Fixed Assets
Net Fixed Assets ⓘ +	4	6	7	8	9	12	12	13	18	40
Gross Block	7	6	7	8	10	16	16	19	24	47
Accumulated Depreciation	3	0	0	1	1	4	5	6	6	7
CWIP ⓘ	0	0	0	0	0	0	0	0	0	12
Investments ⓘ	0	0	0	0	0	1	1	0	5	1
Inventories	11	7	7	9	15	15	13	15	21	42
Trade Receivables	6	7	5	5	5	4	16	17	22	20
Cash Equivalents	1	1	2	1	4	2	6	8	13	9
Others Assets ⓘ	6	5	7	9	8	9	8	11	21	22
Total Assets ⓘ	28	27	28	33	41	43	54	65	100	147

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0	12	6	-4	9
PBT ⓘ	2	6	10	13	11
Adjustment ⓘ	2	2	4	1	4
Changes in Working Capital ⓘ	-4	4	-5	-15	-3
Tax Paid ⓘ	-0	-0	-3	-3	-3
Cash Flow From Investing Activity ⓘ +	-2	-0	-3	-12	-30
Capex	-2	-0	-4	-6	-36
Net Investments	0	0	0	-5	3
Others ⓘ	0	0	1	-2	3
Cash Flow From Financing Activity ⓘ +	1	-8	-1	21	18
Net Proceeds from Shares ⓘ	1	-1	3	22	0
Net Proceeds from Borrowing ⓘ	3	-6	-2	0	20
Interest Paid ⓘ	-2	-2	-2	-1	-2
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	-2	1	-0	0	-0
Net Cash Flow ⓘ	-2	4	3	5	-4

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	13.31	14.89	14.98	15.82	11	13.84	42.56	41.84	25.06	13.8
ROCE (%)	15.66	14.76	14.51	15.23	11.64	14.34	32.89	45.15	29.87	16.58
Asset Turnover Ratio	1.48	1.9	1.85	1.82	1.51	1.42	2.13	1.83	1.28	0.86
PAT to CFO Conversion(x)	0	0	0	0	0	-0	2.4	0.75	-0.4	1.13
Working Capital Days
Receivable Days	48.40	46.90	44.30	34	35.40	29.60	35.10	54.90	67.30	72
Inventory Days	118.40	65.50	52.20	53.50	77.60	90.50	48.80	46.20	62	108.80
Payable Days	113.70	76.20	89.70	95.10	113.80	108.20	74.60	101.80	114.90	153.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hemant Surgical Industries Ltd FAQs

The current trading price of Hemant Surgical Inds on 04-Jun-2026 16:59 is ₹381.4.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Hemant Surgical Inds stood at ₹554.4 Cr

The latest P/E ratio of Hemant Surgical Inds as of 03-Jun-2026 is 30.40.

The latest P/B ratio of Hemant Surgical Inds as of 03-Jun-2026 is 3.86.

The 52-week high of Hemant Surgical Inds is ₹446.0 and the 52-week low is ₹89.99.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hemant Surgical Inds is ₹231 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Hemant Surgical Industries Ltd is a average quality company.

The key valuation ratios of Hemant Surgical Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Hemant Surgical Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Hemant Surgical Industries Ltd

The company was originally incorporated as ‘Hemant Surgical Industries Private Limited’ under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated March 27, 1989, by Registrar of Companies, Maharashtra, Mumbai. Subsequently the company was converted into a public limited company vide special resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 24, 1994 and the name of the company was changed from ‘Hemant Surgical Industries Private Limited’ to ‘Hemant Surgical Industries Limited’ vide fresh Certificate of Incorporation granted to the company consequent upon conversion into public limited company dated February 22, 1994 by the Registrar of Companies, Maharashtra, Mumbai.

The company manufactures, import, assemble and market a comprehensive portfolio of medical equipments and disposables. Its product offerings cover a wide spectrum of equipments and disposables required for (i) Renal Care, (ii) cardiovascular disease (iii) respiratory disease, (iv) Critical Care and Radiology and (v) Surgical disposables. Its wide range of products includes some of the indigenously manufactured products along with some other products that are imported from countries like: Japan, China France and Australia and are further processed in its assembly units. In addition it is also providing services for maintenance and running of dialysis centres.

The company started its operations with importing and marketing of medical disposables like: meditapes, all over India from JMS Company Japan. Later in the year 1999 the company started its manufacturing operations with one Manufacturing unit and over the years expanded its manufacturing and assembly operations to two more additional units. Its facilities are ISO 9001:2015 and ISO 13485:2016 certified having fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing and assembly line process. The company was founded in the year 1989 by one of its Promoters, Hanskumar Shamji Shah, who has over 35 years of experience in the industry.

Business of the company

Hemant surgical Industries is engaged in the business of manufacturing, importing, assembly and marketing of medical equipments and disposables.

Products of the company

Healthcare products and medical equipments

Hemodialysis machine
Dialysis Solution - Acidic and bicarbonate
Dialyzer
ECG machine
ECG electrode
Nebulizer
Paramonitors
Ultrasound machine
Ventilator

Surgical disposables

Meditape
Intravenous infusion set
Scalp vein set
Foley catheter
3 Ply masks

Other healthcare products

Digital thermometer
Cold and hot sterilant
Fully automatic comfort dialysis chair
Five-Function electric ICU bed with mattress

History and milestones

1989: Incorporation of the company in the name of ‘Hemant Surgical Private Limted’.
1993: Became the Sole Agent for JMS Co. Ltd, Japan, for JMS, Meditape.
1994: Conversion into Public Limited company with the name Hemant Surgical Industries Ltd.
1999: Started its first manufacturing plant at Achhad, Maharashtra for External Preparation and Small Volume Parentals.
2018: Entered into exclusive distribution agreement dated July 01, 2018, valid for a period of 6 years, with JMS Co. Ltd., Japan for importing and marketing JMS Meditape in India. The imported meditape undergoes the process of rewinding, slitting, and packaging in its assembly unit situated at Atgaon and is then sold in Indian market.
2019: Entered into technical collaboration agreement with JMS Singapore Pte. Ltd. for manufacturing Intravenous Infusion Set which are sold under the brand name ‘JMS’ in India.
2019: Signed exclusive distribution agreement with Hemant Phillipines Inc./ Mediply Inc. for supply of renal care equipment, medical devices and consumables for marketing the same in entire Phillipines.
2021: Appointed as sole agent of SWS Hemodialysis Care Co. Ltd., Chinato sell and do maintenance of SWS4000A hemodialysis machines in West India on exclusive basis.
2021: Entered into MOU with Dr. Venkatesh for setting up of dialysis centre at Guru Harikrishan Hospital 24x7 Dialysis Centre, New Delhi.
2022: Achieved a Bench mark of 100 Cr Turnover in the FY 2021-22.

Hemant Surgical Industries Ltd (543916)

Hemant Surgical Industries Ltd (543916)

Hemant Surgical Industries stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Hemant Surgical Inds - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hemant Surgical Industries Ltd FAQs

About Hemant Surgical Industries Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Hemant Surgical Industries Ltd (543916)

Hemant Surgical Industries Ltd (543916)

Hemant Surgical Industries stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Hemant Surgical Inds - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hemant Surgical Industries Ltd FAQs

What is the share price of Hemant Surgical Inds?

What is the market cap of Hemant Surgical Inds?

What is the P/E ratio of Hemant Surgical Inds?

What is the P/B ratio of Hemant Surgical Inds?

What is the 52-week high and low of Hemant Surgical Inds?

What is the TTM revenue of Hemant Surgical Inds?

Is Hemant Surgical Industries Ltd a good quality company?

Is Hemant Surgical Industries Ltd undervalued or overvalued?

Is Hemant Surgical Industries Ltd a good buy now?

About Hemant Surgical Industries Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.